Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Photoredox Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117362140A reveals a photoredox synthesis method for cyclohexyl substituted styrenes. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable visible-light catalysis.
Patent CN114539022B reveals a green decarboxylation route for trifluoromethyl alkyl bromides. Discover cost-effective manufacturing and scalable supply chain solutions for fluorinated intermediates.
Patent CN120965536A enables mild photoredox synthesis. Offers supply chain reliability and cost reduction for high-purity pharmaceutical intermediates manufacturing.
Patent CN116730915A enables metal-free asymmetric catalysis. Offers high purity pharmaceutical intermediates with reduced cost and scalable supply chain solutions.
Novel Ti-Ni catalytic method for allyl alcohol compounds reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN103553857A reveals a photocatalytic method for direct ortho-trifluoromethylation. Discover cost reduction in fine chemical manufacturing and scalable supply solutions.
Patent CN114685298A reveals a green photocatalytic route for baclofen. Discover cost-effective, scalable manufacturing solutions for high-purity pharmaceutical intermediates.
Patent CN108484500B reveals a mild iridium-catalyzed route for 1-trifluoroethyl isoquinoline intermediates, offering significant cost reduction and scalable manufacturing advantages.
Patent CN115232164B reveals a visible-light catalyzed method for sulfonyl thiophosphates. This process offers mild conditions and high atom economy for reliable agrochemical intermediate supplier.
Patent CN103467282A details a mild, iridium-catalyzed visible light method for synthesizing polysubstituted naphthols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN114890908B reveals a catalytic method for gamma-trifluoromethyl amino acids using Togni reagents, offering cost reduction in API manufacturing and scalable production.
Patent CN115108875A reveals a metal-free visible light asymmetric method for synthesizing nitrogen-containing chiral cyclic alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN113461597A reveals a cost-effective photoredox/Ni dual catalytic route for nilapanib intermediates, offering significant supply chain stability and reduced manufacturing costs.
Patent CN104803898A enables mild visible light catalysis for aryl sulfides. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN108707081B discloses a mild photocatalytic method for olefin difunctionalization, offering cost reduction in fine chemical manufacturing and reliable supply chain solutions.
Novel photocatalytic route for SC 69124 ensures high purity and supply continuity. Reduces complexity in pharmaceutical intermediates manufacturing for global partners.
Patent CN119912363A reveals a metal-free photoredox method for alpha-aryl cyclic ketones. This breakthrough offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN111548372A reveals a novel iridium-carbene complex enabling room-temperature photocatalysis, offering significant cost reduction in fine chemical manufacturing and reliable supply.
Patent CN113637002B reveals a green photocatalytic route for Nilaparib intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN115650837A reveals a green blue-light copper catalysis method for ketone synthesis, offering safer alternatives to traditional oxidation and Grignard reactions.